Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

A prognostic Bayesian network that makes personalized predictions of poor prognostic outcome post resection of pancreatic ductal adenocarcinoma.

Bradley A, Van der Meer R, McKay CJ.

PLoS One. 2019 Sep 9;14(9):e0222270. doi: 10.1371/journal.pone.0222270. eCollection 2019.

2.

A systematic review of methodological quality of model development studies predicting prognostic outcome for resectable pancreatic cancer.

Bradley A, Van Der Meer R, McKay CJ.

BMJ Open. 2019 Aug 21;9(8):e027192. doi: 10.1136/bmjopen-2018-027192.

3.

PRECISION-Panc: the Next Generation Therapeutic Development Platform for Pancreatic Cancer.

Dreyer SB, Jamieson NB, Cooke SL, Valle JW, McKay CJ, Biankin AV, Chang DK.

Clin Oncol (R Coll Radiol). 2019 Aug 2. pii: S0936-6555(19)30291-2. doi: 10.1016/j.clon.2019.07.011. [Epub ahead of print] No abstract available.

PMID:
31378449
4.

Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis.

Janssen QP, Buettner S, Suker M, Beumer BR, Addeo P, Bachellier P, Bahary N, Bekaii-Saab T, Bali MA, Besselink MG, Boone BA, Chau I, Clarke S, Dillhoff M, El-Rayes BF, Frakes JM, Grose D, Hosein PJ, Jamieson NB, Javed AA, Khan K, Kim KP, Kim SC, Kim SS, Ko AH, Lacy J, Margonis GA, McCarter MD, McKay CJ, Mellon EA, Moorcraft SY, Okada KI, Paniccia A, Parikh PJ, Peters NA, Rabl H, Samra J, Tinchon C, van Tienhoven G, van Veldhuisen E, Wang-Gillam A, Weiss MJ, Wilmink JW, Yamaue H, Homs MYV, van Eijck CHJ, Katz MHG, Koerkamp BG.

J Natl Cancer Inst. 2019 May 14. pii: djz073. doi: 10.1093/jnci/djz073. [Epub ahead of print]

PMID:
31086963
5.

Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling.

Dreyer SB, Jamieson NB, Evers L, Duthie F, Cooke S, Marshall J, Beraldi D, Knight S, Upstill-Goddard R, Dickson EJ, Carter CR, McKay CJ, Biankin AV, Chang DK.

Chin Clin Oncol. 2019 Apr;8(2):16. doi: 10.21037/cco.2019.04.06.

6.

Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer.

Dreyer SB, Pinese M, Jamieson NB, Scarlett CJ, Colvin EK, Pajic M, Johns AL, Humphris JL, Wu J, Cowley MJ, Chou A, Nagrial AM, Chantrill L, Chin VT, Jones MD, Moran-Jones K, Carter CR, Dickson EJ, Samra JS, Merrett ND, Gill AJ, Kench JG, Duthie F, Miller DK, Cooke S, Aust D, Knösel T, Rümmele P, Grützmann R, Pilarsky C, Nguyen NQ, Musgrove EA, Bailey PJ, McKay CJ, Biankin AV, Chang DK; Australian Pancreatic Cancer Genome Initiative; Glasgow Precision Oncology Laboratory.

Ann Surg. 2018 Nov 30. doi: 10.1097/SLA.0000000000003143. [Epub ahead of print]

PMID:
30570546
7.

Defining the molecular pathology of pancreatic body and tail adenocarcinoma.

Dreyer SB, Jamieson NB, Upstill-Goddard R, Bailey PJ, McKay CJ; Australian Pancreatic Cancer Genome Initiative, Biankin AV, Chang DK.

Br J Surg. 2018 Jan;105(2):e183-e191. doi: 10.1002/bjs.10772.

8.

The role of induction chemotherapy + chemoradiotherapy in localised pancreatic cancer: initial experience in Scotland.

Grose D, McIntosh D, Jamieson N, Carter R, Dickson E, Chang D, Marashi H, Wilson C, Alfayez M, Kerr A, O'Donoghue R, Haskins L, Duthie F, McKay CJ, Graham J.

J Gastrointest Oncol. 2017 Aug;8(4):683-695. doi: 10.21037/jgo.2017.04.01.

9.

Minimally invasive and endoscopic versus open necrosectomy for necrotising pancreatitis: a pooled analysis of individual data for 1980 patients.

van Brunschot S, Hollemans RA, Bakker OJ, Besselink MG, Baron TH, Beger HG, Boermeester MA, Bollen TL, Bruno MJ, Carter R, French JJ, Coelho D, Dahl B, Dijkgraaf MG, Doctor N, Fagenholz PJ, Farkas G, Castillo CFD, Fockens P, Freeman ML, Gardner TB, Goor HV, Gooszen HG, Hannink G, Lochan R, McKay CJ, Neoptolemos JP, Oláh A, Parks RW, Peev MP, Raraty M, Rau B, Rösch T, Rovers M, Seifert H, Siriwardena AK, Horvath KD, van Santvoort HC.

Gut. 2018 Apr;67(4):697-706. doi: 10.1136/gutjnl-2016-313341. Epub 2017 Aug 3.

10.

Hypermutation In Pancreatic Cancer.

Humphris JL, Patch AM, Nones K, Bailey PJ, Johns AL, McKay S, Chang DK, Miller DK, Pajic M, Kassahn KS, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Stone A, Wilson PJ, Anderson M, Fink JL, Holmes O, Kazakoff S, Leonard C, Newell F, Waddell N, Wood S, Mead RS, Xu Q, Wu J, Pinese M, Cowley MJ, Jones MD, Nagrial AM, Chin VT, Chantrill LA, Mawson A, Chou A, Scarlett CJ, Pinho AV, Rooman I, Giry-Laterriere M, Samra JS, Kench JG, Merrett ND, Toon CW, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, McKay CJ, Carter CR, Dickson EJ, Graham JS, Duthie F, Oien K, Hair J, Morton JP, Sansom OJ, Grützmann R, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Rusev B, Corbo V, Salvia R, Cataldo I, Tortora G, Tempero MA; Australian Pancreatic Cancer Genome Initiative, Hofmann O, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Gill AJ, Pearson JV, Grimmond SM, Waddell N, Biankin AV.

Gastroenterology. 2017 Jan;152(1):68-74.e2. doi: 10.1053/j.gastro.2016.09.060. Epub 2016 Nov 15.

PMID:
27856273
11.

The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms: a systematic update.

Smith LA, McKay CJ.

Minerva Med. 2016 Dec;107(6):370-380. Epub 2016 Sep 14. Review.

PMID:
27627636
12.

A Glasgow Tipple-transjugular intrahepatic portosystemic shunt insertion prior to Whipple resection.

Jabbar SA, Jamieson NB, Morris AJ, Oien KA, Duthie F, McKay CJ, Carter CR, Dickson EJ.

J Surg Case Rep. 2016 May 13;2016(5). pii: rjw089. doi: 10.1093/jscr/rjw089.

13.

Serum amylase and C-reactive protein in risk stratification of pancreas-specific complications after pancreaticoduodenectomy.

Palani Velu LK, McKay CJ, Carter CR, McMillan DC, Jamieson NB, Dickson EJ.

Br J Surg. 2016 Apr;103(5):553-63. doi: 10.1002/bjs.10098. Epub 2016 Feb 22.

PMID:
26898605
14.

Prospective cohort study comparing transient EUS guided elastography to EUS-FNA for the diagnosis of solid pancreatic mass lesions.

Mayerle J, Beyer G, Simon P, Dickson EJ, Carter RC, Duthie F, Lerch MM, McKay CJ.

Pancreatology. 2016 Jan-Feb;16(1):110-4. doi: 10.1016/j.pan.2015.10.003. Epub 2015 Nov 2.

PMID:
26602088
15.

RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial.

Palani Velu LK, Steele CW, Dickson EJ, Carter CR, McKay CJ, Horgan PG, McMillan DC, Jamieson NB.

J Natl Cancer Inst. 2015 Aug 6;107(9). pii: djv204. doi: 10.1093/jnci/djv204. Print 2015 Sep. No abstract available.

16.

SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer Patients.

McGlynn LM, McCluney S, Jamieson NB, Thomson J, MacDonald AI, Oien K, Dickson EJ, Carter CR, McKay CJ, Shiels PG.

PLoS One. 2015 Jun 29;10(6):e0131344. doi: 10.1371/journal.pone.0131344. eCollection 2015.

17.

IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival.

Lunardi S, Jamieson NB, Lim SY, Griffiths KL, Carvalho-Gaspar M, Al-Assar O, Yameen S, Carter RC, McKay CJ, Spoletini G, D'Ugo S, Silva MA, Sansom OJ, Janssen KP, Muschel RJ, Brunner TB.

Oncotarget. 2014 Nov 30;5(22):11064-80.

18.

Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel.

Ali A, Brown V, Denley S, Jamieson NB, Morton JP, Nixon C, Graham JS, Sansom OJ, Carter CR, McKay CJ, Duthie FR, Oien KA.

BMC Clin Pathol. 2014 Jul 23;14:35. doi: 10.1186/1472-6890-14-35. eCollection 2014.

19.

The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms.

Smith LA, Mckay CJ.

Minerva Med. 2014 Oct;105(5):413-21. Epub 2014 Jul 7. Review.

PMID:
25000220
20.

Routine Drainage After Pancreaticoduodenectomy: Serum Amylase Can Guide Early, Selective Drain Removal.

Palani Velu LK, Chandrabalan V, McMillan DC, McKay CJ, Carter CR, Jamieson NB, Dickson EJ.

Ann Surg. 2015 Dec;262(6):e107. doi: 10.1097/SLA.0000000000000758. No abstract available.

PMID:
24887980
21.

Targeting mTOR dependency in pancreatic cancer.

Morran DC, Wu J, Jamieson NB, Mrowinska A, Kalna G, Karim SA, Au AY, Scarlett CJ, Chang DK, Pajak MZ; Australian Pancreatic Cancer Genome Initiative (APGI), Oien KA, McKay CJ, Carter CR, Gillen G, Champion S, Pimlott SL, Anderson KI, Evans TR, Grimmond SM, Biankin AV, Sansom OJ, Morton JP.

Gut. 2014 Sep;63(9):1481-9. doi: 10.1136/gutjnl-2013-306202. Epub 2014 Apr 9.

22.

Investigation and management of pancreatic tumours.

Smith LA, Jamieson NB, McKay CJ.

Frontline Gastroenterol. 2014 Apr;5(2):144-152. doi: 10.1136/flgastro-2013-100364. Epub 2013 Oct 11. Review.

23.

Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomy.

Palani Velu LK, Chandrabalan VV, Jabbar S, McMillan DC, McKay CJ, Carter CR, Jamieson NB, Dickson EJ.

HPB (Oxford). 2014 Jul;16(7):610-9. doi: 10.1111/hpb.12184. Epub 2013 Nov 7.

24.

Photon doses in NPL standard neutron fields.

Roberts NJ, Horwood NA, McKay CJ.

Radiat Prot Dosimetry. 2014 Oct;161(1-4):157-60. doi: 10.1093/rpd/nct249. Epub 2013 Oct 14.

PMID:
24126485
25.

Reply to G.F. Arroyo.

Chang DK, Jamieson NB, Scarpa A, McKay CJ, Biankin AV.

J Clin Oncol. 2013 Oct 20;31(30):3843-4. doi: 10.1200/JCO.2013.51.3176. Epub 2013 Sep 16. No abstract available.

PMID:
24043730
26.

'Step-port' laparoscopic cystgastrostomy for the management of organized solid predominant post-acute fluid collections after severe acute pancreatitis.

Gibson SC, Robertson BF, Dickson EJ, McKay CJ, Carter CR.

HPB (Oxford). 2014 Feb;16(2):170-6. doi: 10.1111/hpb.12099. Epub 2013 Mar 29.

27.

Pre-operative cardiopulmonary exercise testing predicts adverse post-operative events and non-progression to adjuvant therapy after major pancreatic surgery.

Chandrabalan VV, McMillan DC, Carter R, Kinsella J, McKay CJ, Carter CR, Dickson EJ.

HPB (Oxford). 2013 Nov;15(11):899-907. doi: 10.1111/hpb.12060. Epub 2013 Feb 20.

28.

Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.

Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C, Nagrial AM, Chantrill LA, Chin VT, Pinho AV, Rooman I, Cowley MJ, Wu J, Mead RS, Colvin EK, Samra JS, Corbo V, Bassi C, Falconi M, Lawlor RT, Crippa S, Sperandio N, Bersani S, Dickson EJ, Mohamed MA, Oien KA, Foulis AK, Musgrove EA, Sutherland RL, Kench JG, Carter CR, Gill AJ, Scarpa A, McKay CJ, Biankin AV.

J Clin Oncol. 2013 Apr 1;31(10):1348-56. doi: 10.1200/JCO.2012.46.8868. Epub 2013 Feb 25.

PMID:
23439753
29.

Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma.

Denley SM, Jamieson NB, McCall P, Oien KA, Morton JP, Carter CR, Edwards J, McKay CJ.

J Gastrointest Surg. 2013 May;17(5):887-98. doi: 10.1007/s11605-013-2168-7. Epub 2013 Feb 23.

PMID:
23435739
30.

Exploiting inflammation for therapeutic gain in pancreatic cancer.

Steele CW, Jamieson NB, Evans TR, McKay CJ, Sansom OJ, Morton JP, Carter CR.

Br J Cancer. 2013 Mar 19;108(5):997-1003. doi: 10.1038/bjc.2013.24. Epub 2013 Feb 5. Review.

31.

The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Jamieson NB, Chan NI, Foulis AK, Dickson EJ, McKay CJ, Carter CR.

J Gastrointest Surg. 2013 Mar;17(3):511-21. doi: 10.1007/s11605-012-2131-z. Epub 2013 Jan 8.

PMID:
23297028
32.

The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma.

Jamieson NB, Mohamed M, Oien KA, Foulis AK, Dickson EJ, Imrie CW, Carter CR, McKay CJ, McMillan DC.

Ann Surg Oncol. 2012 Oct;19(11):3581-90. doi: 10.1245/s10434-012-2370-y. Epub 2012 May 4.

PMID:
22555345
33.

Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression.

Dozynkiewicz MA, Jamieson NB, Macpherson I, Grindlay J, van den Berghe PV, von Thun A, Morton JP, Gourley C, Timpson P, Nixon C, McKay CJ, Carter R, Strachan D, Anderson K, Sansom OJ, Caswell PT, Norman JC.

Dev Cell. 2012 Jan 17;22(1):131-45. doi: 10.1016/j.devcel.2011.11.008. Epub 2011 Dec 22.

34.

MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma.

Jamieson NB, Morran DC, Morton JP, Ali A, Dickson EJ, Carter CR, Sansom OJ, Evans TR, McKay CJ, Oien KA.

Clin Cancer Res. 2012 Jan 15;18(2):534-45. doi: 10.1158/1078-0432.CCR-11-0679. Epub 2011 Nov 23.

35.

Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.

Steele CW, Oien KA, McKay CJ, Jamieson NB.

Pancreas. 2011 Nov;40(8):1165-71. doi: 10.1097/MPA.0b013e3182218ffb. Review.

PMID:
22001830
36.

Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.

Jamieson NB, Carter CR, McKay CJ, Oien KA.

Clin Cancer Res. 2011 May 15;17(10):3316-31. doi: 10.1158/1078-0432.CCR-10-3284. Epub 2011 Mar 28. Review.

37.

A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma.

Jamieson NB, Denley SM, Logue J, MacKenzie DJ, Foulis AK, Dickson EJ, Imrie CW, Carter R, McKay CJ, McMillan DC.

Ann Surg Oncol. 2011 Aug;18(8):2318-28. doi: 10.1245/s10434-011-1560-3. Epub 2011 Jan 26.

PMID:
21267785
38.

Peripancreatic fat invasion is an independent predictor of poor outcome following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Jamieson NB, Foulis AK, Oien KA, Dickson EJ, Imrie CW, Carter R, McKay CJ.

J Gastrointest Surg. 2011 Mar;15(3):512-24. doi: 10.1007/s11605-010-1395-4. Epub 2010 Nov 30.

PMID:
21116727
39.

Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding.

Rajoriya N, Forrest EH, Gray J, Stuart RC, Carter RC, McKay CJ, Gaya DR, Morris AJ, Stanley AJ.

QJM. 2011 Jan;104(1):41-7. doi: 10.1093/qjmed/hcq161. Epub 2010 Sep 25.

PMID:
20871126
40.

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore MJ, Gallinger S, Mariette C, Wente MN, Izbicki JR, Friess H, Lerch MM, Dervenis C, Oláh A, Butturini G, Doi R, Lind PA, Smith D, Valle JW, Palmer DH, Buckels JA, Thompson J, McKay CJ, Rawcliffe CL, Büchler MW; European Study Group for Pancreatic Cancer.

JAMA. 2010 Sep 8;304(10):1073-81. doi: 10.1001/jama.2010.1275.

PMID:
20823433
41.

Infected pancreatic necrosis: minimizing the cut.

Wysocki AP, McKay CJ, Carter CR.

ANZ J Surg. 2010 Jan;80(1-2):58-70. doi: 10.1111/j.1445-2197.2009.05177.x. Review.

PMID:
20575882
42.

Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma.

Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ, Imrie CW, McKay CJ, Carter R.

Ann Surg. 2010 Jun;251(6):1003-10. doi: 10.1097/SLA.0b013e3181d77369.

PMID:
20485150
43.

LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest.

Morton JP, Jamieson NB, Karim SA, Athineos D, Ridgway RA, Nixon C, McKay CJ, Carter R, Brunton VG, Frame MC, Ashworth A, Oien KA, Evans TR, Sansom OJ.

Gastroenterology. 2010 Aug;139(2):586-97, 597.e1-6. doi: 10.1053/j.gastro.2010.04.055. Epub 2010 May 6.

44.

Incarcerated small bowel within a spontaneous lumbar hernia.

Teo KA, Burns E, Garcea G, Abela JE, McKay CJ.

Hernia. 2010 Oct;14(5):539-41. doi: 10.1007/s10029-009-0581-3. Epub 2009 Nov 5.

PMID:
19890674
45.

Chronic inflammation and pancreatic cancer.

McKay CJ, Glen P, McMillan DC.

Best Pract Res Clin Gastroenterol. 2008;22(1):65-73. doi: 10.1016/j.bpg.2007.11.007. Review.

PMID:
18206813
46.

Identification of mixed-symmetry states in an odd-mass nearly spherical nucleus.

Orce JN, Holt JD, Linnemann A, McKay CJ, Lesher SR, Fransen C, Holt JW, Kumar A, Warr N, Werner V, Jolie J, Kuo TT, McEllistrem MT, Pietralla N, Yates SW.

Phys Rev Lett. 2006 Aug 11;97(6):062504. Epub 2006 Aug 10.

PMID:
17026168
47.

Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer.

Glen P, Jamieson NB, McMillan DC, Carter R, Imrie CW, McKay CJ.

Pancreatology. 2006;6(5):450-3. Epub 2006 Jul 13.

PMID:
16847382
48.

Cholangiography is no substitute.

Wysocki AP, McKay CJ, Carter CR, Imrie CW.

ANZ J Surg. 2006 Jun;76(6):536. No abstract available.

PMID:
16768785
49.

The outcome of laparoscopic gastrojejunostomy in malignant gastric outlet obstruction.

Denley SM, Moug SJ, Carter CR, McKay CJ.

Int J Gastrointest Cancer. 2005;35(3):165-9.

PMID:
16110117
50.

A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis.

Eatock FC, Chong P, Menezes N, Murray L, McKay CJ, Carter CR, Imrie CW.

Am J Gastroenterol. 2005 Feb;100(2):432-9.

PMID:
15667504

Supplemental Content

Loading ...
Support Center